Facebook
Twitter
LinkedIn
ForwardWebinar: What General Urologists Can Do To Comprehensively Evaluate & Successfully Treat Male Infertility (2020)
Course Director: Marc Goldstein, MD
This course will focus on what general urologists who have not had fellowship or specialty training in male infertility can do to evaluate and treat male reproductive disorders. Basic science presented will be limited to that which is absolutely essential to understand the basic evaluation and treatment.
In 90% of male infertility cases, a good history and careful physical examination, along with a basic semen analysis, which can often be performed by the doctor himself, will allow the general urologist to come up with a tentative diagnosis and treatment plan. More advanced testing is primarily designed to confirm the diagnosis. Key points of history, including inheritance issues, will be discussed. The finer points of physical examination, which in male infertility, due to the ready accessibility of the male reproductive organs to physical examination of a relaxed scrotum, allows the diagnosis to be made without the necessity for imaging studies in the majority of men.
Interpretation of semen analysis will be discussed. When and what endocrine evaluations should be performed, including indications for genetic testing such as microY deletion assays and karyotype. When more advanced sperm testing, such as DNA fragmentation and anti-sperm antibody assays, are indicated as well as indications for imaging such a scrotal ultrasound, transrectal ultrasound and testis biopsy. The performance of basic office ultrasound, done by the general urologist, will be explained and the images obtained will be interpreted. The most likely diagnoses resulting from this evaluation will be discussed and treatments that can be employed by general urologists without fellowship training will be gone over in great detail. This will include medical treatments, basic surgical treatments that can be performed by general urologists with minimal microsurgical training and lifestyle recommendations, including supplements that may be of value. A limited presentation of advanced evaluation and treatment methods employed by fellowship trained specialists will be described and the indications for referral to such specialists presented.
Please note this course is FREE to all AUA Members and is an exclusive member benefit. If you would like to become an AUA Member, we'd be happy to have you - think about all the great member benefits!
Target Audience
- Urologists
- Residents
- Advanced Practice Providers (Nurse Practitioners and Physician Assistants)
Learning Objectives
Upon completion of this activity, participants will be able to:
- Perform a practical, cost-effective office and laboratory evaluation of the infertile male.
- Select which medical and surgical treatments are effective and can be employed by general urologists without specialty training.
- Identify when to refer to fellowship-trained specialists, and when to collaborate with IVF doctors.
- List the risk factors for both future infertility and androgen deficiency and how to treat them.
- Upon completion of the course, participant will be able to select appropriate diagnostic treatment codes to get the best reimbursements.
Scientific Agenda
Welcome, Housekeeping Notes
AUA
Introduction
Marc Goldstein, MD, DSc (hon), FACS
Infertility Evaluation of the Male
Mark Sigman, MD
Azoospermia – How to Evaluate
Mark Sigman, MD
Medical Therapy
Mark Sigman, MD
Surgical Therapy
Marc Goldstein, MD, DSc (hon), FACS
Assisted Reproductive Technologies – the Role of the Urologist
Peter Chan, MD, CM, MSc, FRCS (C), FACS
Diagnosis Codes
Marc Goldstein, MD, DSc (hon), FACS
Q&A
All Faculty
WEBINAR ADJOURNS – BROADCAST ENDS
What General Urologists Can Do To Comprehensively Evaluate & Successfully Treat Male Infertility (2020) will be held virtually on Thursday, June 18 at 1:00 PM EST.
***Instructions***
- Click the "Register" tab.
- If prompted, click “update your profile”. Otherwise, click “Take Course”.
- Click “Start” under Live Webinar in the Course Progress pane.
- Click "Join Webinar".
Education Council Disclosures
EC Disclosures _June 1 20 through Dec 31 20.pdf
AUA Office of Education Staff has nothing to disclose.
Marc Goldstein, MD
Peter Chan, MD
Mark Sigman, MD
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA Participant Information and Policies
DISCLAIMER:
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:
The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.
REPRODUCTION PERMISSION:
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
SPECIAL ASSISTANCE/DIETARY NEEDS:
The AUA complies with the Americans with Disabilities Act §12112(a).
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation